S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells

Urology

Volumn 85, Issue 1, 2015, Pages 273.e9-273.e15

  Kang, Minyong ^a   Lee, Hye Sun ^a   Lee, Young Ju ^a   Choi, Woo Suk ^b   Park, Yong Hyun ^c   Jeong, Chang Wook ^a   Ku, Ja Hyeon ^a   Kim, Hyeon Hoe ^a   Kwak, Cheol ^a  

^a Seoul National University Hospital   (South Korea)

^b Konkuk University Hospital   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PROTEIN S 100; PROTEIN S100A3; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; S100A3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CASTRATION RESISTANT PROSTATE CANCER; CELL COUNTING; CELL FRACTIONATION; CELL MIGRATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; NUDE MOUSE; PATHOLOGY; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; TUMOR CELL CULTURE;

ANIMALS; HUMANS; IN VITRO TECHNIQUES; MALE; MICE, NUDE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; S100 PROTEINS; TUMOR CELLS, CULTURED;

EID: 84918831006     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.09.018     Document Type: Article

References (25)

1. F.H. Schroder Prostate cancer around the world. An overview Urol Oncol 28 2010 663 667
2. T.M. Amaral, D. Macedo, and I. Fernandes Castration-resistant prostate cancer: mechanisms, targets, and treatment Prostate Cancer 2012 2012 327253
3. N. Sharifi, M.J. McPhaul, and R.J. Auchus "Getting from here to there" - mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer J Investig Med 58 2010 938 944
4. J. Ansari, S.A. Hussain, and A. Zarkar Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment: Birmingham experience Oncol Rep 20 2008 891 896
5. N. Sharifi, W.L. Dahut, and S.M. Steinberg A retrospective study of the time to clinical endpoints for advanced prostate cancer BJU Int 96 2005 985 989
6. H. Chen, C. Xu, and Q. Jin S100 protein family in human cancer Am J Cancer Res 4 2014 89 115
7. W.C. Tsai, S.T. Tsai, and Y.T. Jin Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma Mol Cancer Res 4 2006 539 547
8. S. Naz, M. Bashir, and P. Ranganathan Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3 Carcinogenesis 35 2014 14 23
9. Y.H. Park, S.Y. Seo, and E. Lee Simvastatin induces apoptosis in castrate resistant prostate cancer cells by deregulating nuclear factor-κB pathway J Urol 189 2013 1547 1552
10. M. Kang, C.W. Jeong, and J.H. Ku Inhibition of autophagy potentiates atorvastatin-induced apoptotic cell death in human bladder cancer cells in vitro Int J Mol Sci 15 2014 8106 8121
11. I. Salama, P.S. Malone, and F. Mihaimeed A review of the S100 proteins in cancer Eur J Surg Oncol 34 2008 357 364
12. D.B. Zimmer, E.H. Cornwall, and A. Landar The S100 protein family: history, function, and expression Brain Res Bull 37 1995 417 429
13. M.W. Nasser, Z. Qamri, and Y.S. Deol S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways Cancer Res 72 2012 604 615
14. M. Sakaguchi, H. Murata, and H. Sonegawa Truncation of annexin A1 is a regulatory lever for linking epidermal growth factor signaling with cytosolic phospholipase A2 in normal and malignant squamous epithelial cells J Biol Chem 282 2007 35679 35686
15. S. Gupta, T. Hussain, and G.T. MacLennan Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma J Clin Oncol 21 2003 106 112
16. M. Saleem, M.H. Kweon, and J.J. Johnson S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 Proc Natl Acad Sci USA 103 2006 14825 14830
17. K. Kizawa, H. Uchiwa, and U. Murakami Highly-expressed S100A3, a calcium-binding protein, in human hair cuticle Biochim Biophys Acta 1312 1996 94 98
18. B.H. Lloyd, C. Ruddell, and P.S. Rudland S100A3 mRNA expression displays an inverse correlation to breast cancer progression Biochem Soc Trans 24 1996 340S
19. B. Liu, W.Y. Sun, and C.Y. Zhi Role of S100A3 in human colorectal cancer and the anticancer effect of cantharidinate Exp Ther Med 6 2013 1499 1503
20. P.Z. Khasigov, O.V. Podobed, and T.S. Gracheva Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis Biochemistry 68 2003 711 717
21. W.G. Stetler-Stevenson The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis Surg Oncol Clin N Am 10 2001 383 392 x
22. I. Stamenkovic Matrix metalloproteinases in tumor invasion and metastasis Semin Cancer Biol 10 2000 415 433
23. W.A. Satariano, K.E. Ragland, and S.K. Van Den Eeden Cause of death in men diagnosed with prostate carcinoma Cancer 83 1998 1180 1188
24. S.M. Pulukuri, C.S. Gondi, and S.S. Lakka RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo J Biol Chem 280 2005 36529 36540
25. S. Jayakumar, A. Kunwar, and S.K. Sandur Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity Biochim Biophys Acta 1840 2014 485 494